Let’s cover six scientifically backed methods to address the post-stem cell transplant procedure side effects you may be experiencing.

Mesoblast’s achievement in winning approval for its Ryoncil drug in the US in December heralds the arrival of a new class of ...

Mesoblast stock climbs 80% in a month following the FDA's approval of Ryoncil as the only approved therapy for SR-aGVHD in children aged two months and older.

Mesoblast's FDA approval for remestemcel marks a milestone for MSC therapies, but limited cash reserves pose risks for US ...

Progesterone is under clinical development by Glia and currently in Phase III for Graft Versus Host Disease (GVHD).

Morgans's healthcare analyst Iain Wilkie describes 2024 as "pretty patchy" for the ASX healthcare sector, which has ...

fantasy cricket expert Strategies for the development of new drugs for graft-versus-host disease (GVHD) $100 million! Hausen Pharmaceuticals licenses EQRx to acquire rights to Ametinib outside China ...

In an interview with Peers & Perspectives in Oncology, Doris M. Ponce, MD, MS, a bone marrow transplant specialist, discussed how telehealth made a significant impact on patients with rare diseases ...

INR:4950. january 2023 ka satta king Academician Chen Wei: The Chinese virus "hunter" who "strikes back" in retrograde HEC Pharmaceutical's "Recombinan ...

INR:6468. gta san 1 century-old miracle drug & 2 billion-dollar products & 4 blockbuster drugs: the future of antithrombotic drugs is still promising Strategies for the d ...

LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; and LP-410, an oral liposomal formulation of tacrolimus for the treatment of oral graft-versus-host disease (GVHD).